Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-67,436
Closed -$927K 831
2025
Q2
$927K Sell
67,436
-13,655
-17% -$185K ﹤0.01% 905
2025
Q1
$1.01M Buy
81,091
+18,730
+30% +$236K ﹤0.01% 843
2024
Q4
$829K Buy
62,361
+39,764
+176% +$458K ﹤0.01% 887
2024
Q3
$254K Buy
+22,597
New +$325K ﹤0.01% 1026
2023
Q2
Sell
-30,307
Closed -$469K 1151
2023
Q1
$469K Buy
30,307
+528
+2% +$8.92K ﹤0.01% 973
2022
Q4
$549K Buy
+29,779
New +$877K ﹤0.01% 980

Other funds holding RIVN

Axa's RIVN Position: Q3 2025 in Review

Axa sold out of Rivian (RIVN) in Q3 2025, closing a stake of 67,436 shares — an estimated $927K sold.

Axa first reported a position in RIVN in Q4 2022 and held it in 6 quarters. The position peaked at $1.01M in Q1 2025. 754 funds tracked by Wall St. Rank hold RIVN as of Q3 2025.

  • Axa reported no remaining Rivian position as of Q3 2025 after selling out during the quarter.
  • Axa sold 67,436 Rivian shares in Q3 2025, an estimated $927K.
  • Axa first reported a position in Rivian in Q4 2022 and held it in 6 quarters.
  • Axa's Rivian position peaked at $1.01M in Q1 2025.
  • 754 funds tracked by Wall St. Rank held Rivian as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.